Bernard Calandra

4.9k citations
16 papers · 4.3k · 2 hit papers · h-index 15

Impact in

Papers in

Bernard Calandra

16 papers receiving 4.2k citations

Bernard Calandra's Hit Papers

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor 1998 · 618 citations
6180+10+21Years since publication50010001.5k

Peers

Bernard Calandra
Comparison fields: 5 of 83
  • Pharmacology 3.9k
  • Cellular and Molecular Neuroscience 2.5k
  • Toxicology 405
  • Endocrine and Autonomic Systems 569
  • Cognitive Neuroscience 740
Replace Murielle Rinaldi‐Carmona with:
Murielle Rinaldi‐Carmona France
Francis Barth France
Michael Bayewitch Israel
Shinji Nakane Japan
Lisa A. Matsuda United States
Christian Congy France
C. S. Breivogel United States
Alex Straiker United States
Laura J. Sim‐Selley United States
Jeanne Maruani France
Bernard Calandra relative to Murielle Rinaldi‐Carmona France Murielle Rinaldi‐Carmona's profile →
Citations per field
00.5×1.5×
Murielle Rinaldi‐Carmona · 1×
Citations per year

Countries citing papers authored by Bernard Calandra

Since Specialization
Citations

This map shows the geographic impact of Bernard Calandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Calandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Calandra more than expected).

Fields of papers citing papers by Bernard Calandra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Calandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Calandra. The network helps show where Bernard Calandra may publish in the future.

Co-authors

The 25 scholars most cited alongside Bernard Calandra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernard Calandra Line = papers co-authored together Bernard Calandra links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Hit paper breakdown →
19941560
2
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Hit paper breakdown →
1998618
3 1995471
4 1997420
5 1995283
6 1996253
7 1996178
8 1996108
9 199992
10 199689
11 199989
12 199986
13 200053
14 199726
15 199614
16 20021

About Bernard Calandra

Bernard Calandra is a scholar working on Pharmacology, Cellular and Molecular Neuroscience, Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism, having authored 16 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (15 papers), Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (6 papers), Pancreatic function and diabetes (5 papers), Diet, Metabolism, and Disease (3 papers), GABA and Rice Research (3 papers), Neuroscience of respiration and sleep (2 papers) and Polyamine Metabolism and Applications (2 papers). The work is most often cited by research in Pharmacology (3.9k citations), Cellular and Molecular Neuroscience (2.5k citations), Toxicology (405 citations), Endocrine and Autonomic Systems (569 citations) and Cognitive Neuroscience (740 citations). Bernard Calandra has collaborated with scholars based in France and United Kingdom. Frequent co-authors include Gérard Le Fur, David Shire, Murielle Rinaldi‐Carmona, Francis Barth, Pierre Casellas, Pascual Ferrara, Monsif Bouaboula, Daniel Caput, Christian Congy and M Rinaldi-Carmona. Their work appears in journals such as Journal of Biological Chemistry, Journal of Pharmacology and Experimental Therapeutics, European Journal of Pharmacology, European Journal of Biochemistry and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact